Y Intercept Hong Kong Ltd Sells 318,294 Shares of Varex Imaging $VREX

Y Intercept Hong Kong Ltd lessened its stake in shares of Varex Imaging (NASDAQ:VREX) by 92.6% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 25,303 shares of the company’s stock after selling 318,294 shares during the period. Y Intercept Hong Kong Ltd owned 0.06% of Varex Imaging worth $314,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Pzena Investment Management LLC boosted its stake in Varex Imaging by 11.6% during the second quarter. Pzena Investment Management LLC now owns 4,244,977 shares of the company’s stock valued at $36,804,000 after buying an additional 442,628 shares during the last quarter. Qube Research & Technologies Ltd boosted its position in shares of Varex Imaging by 2,514.9% during the 2nd quarter. Qube Research & Technologies Ltd now owns 318,127 shares of the company’s stock valued at $2,758,000 after acquiring an additional 305,961 shares during the last quarter. Neuberger Berman Group LLC increased its position in Varex Imaging by 22.8% in the second quarter. Neuberger Berman Group LLC now owns 1,497,175 shares of the company’s stock worth $12,974,000 after purchasing an additional 277,870 shares during the last quarter. Federated Hermes Inc. bought a new stake in Varex Imaging in the second quarter worth $1,946,000. Finally, American Century Companies Inc. lifted its position in Varex Imaging by 88.3% during the second quarter. American Century Companies Inc. now owns 414,296 shares of the company’s stock valued at $3,592,000 after purchasing an additional 194,235 shares during the last quarter.

Varex Imaging Price Performance

Shares of VREX stock opened at $13.78 on Friday. The stock has a 50 day moving average price of $12.68 and a 200 day moving average price of $11.55. The firm has a market capitalization of $577.66 million, a P/E ratio of -8.11 and a beta of 0.90. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.83 and a current ratio of 3.43. Varex Imaging has a 52-week low of $6.76 and a 52-week high of $15.46.

Varex Imaging (NASDAQ:VREX) last released its earnings results on Tuesday, November 18th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.18 by $0.19. The business had revenue of $228.90 million for the quarter, compared to analyst estimates of $219.26 million. Varex Imaging had a positive return on equity of 7.19% and a negative net margin of 8.32%.Varex Imaging has set its Q1 2026 guidance at 0.050-0.250 EPS. As a group, sell-side analysts predict that Varex Imaging will post 0.53 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on VREX. Wall Street Zen upgraded shares of Varex Imaging from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 22nd. Jefferies Financial Group reissued a “hold” rating and set a $14.50 price objective on shares of Varex Imaging in a research note on Monday. Oppenheimer lowered their price objective on Varex Imaging from $23.00 to $18.00 and set an “outperform” rating for the company in a research note on Wednesday, November 19th. Weiss Ratings reissued a “sell (d-)” rating on shares of Varex Imaging in a research report on Monday, December 29th. Finally, B. Riley restated a “buy” rating and set a $16.00 price target on shares of Varex Imaging in a report on Wednesday, November 19th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Varex Imaging has an average rating of “Hold” and an average target price of $16.17.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.